CCL5 and prostate cancer: Chemokines secreted by ECs (such as CXCL1/CXCL8/CCL5) guide the directional migration of CTCs through gradients, with CCL5 activating the androgen receptor to increase the invasiveness of prostate cancer 119, 120.